This page holds the current immunisation patient group directions (PGDs) authorised by GMHSCP.
Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to documents authorised in accordance with HMR 2012 schedule 16 part 2.
Individual practitioners must be authorised by name, under the current version of the PGD before working according to it.
These PGDs should be used with reference to the Green Book, and summary of product characteristics for the vaccine.
- COVID-19 mRNA vaccine (5 to 17 years of age) PGD v03.00
- COVID-19 mRNA vaccine (5 to 17 years of age) national protocol v03.00
- COVID-19 vaccine (adults) PGD v04.00
- COVID-19 vaccine (adults) national protocol v04.00
- Diphtheria, Tetanus, Acellular Pertussis and Inactivated Poliomyelitis Vaccine (dTaP/IPV) PGD v05.00
- Diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b and hepatitis B vaccine (DTaP/IPV/Hib/HepB) PGD v04.00
- Low dose diptheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV) PGD v05.00
- Hepatitis A vaccine PGD v05.00
- Hepatitis A/B vaccine PGD v04.00
- Hepatitis A/Typhoid vaccine PGD v03.00
- Hepatitis B vaccine PGD v05.00
- Hepatitis B Renal vaccine PGD v04.00
- Haemophilus influenzae type b and meningococcal C conjugate vaccine (Hib/MenC) PGD v05.00
- Human Papillomavirus (HPV) Vaccine PGD v06.00
- Inactivated influenza vaccine PGD V12.00
- Inactivated influenza vaccine National Protocol v05.00
- Live attenuated influenza vaccine nasal spray suspension (LAIV) PGD V13.00
- Meningococcal group A, C, W and Y conjugate vaccine (MenACWY) PGD v05.00
- Meningococcal group A, C, W and Y conjugate vaccine (MenACWY) for risk groups PGD v04.00
- Meningococcal group B vaccine PGD v06.00
- Meningococcal group B vaccine for risk groups PGD v04.00
- Measles, mumps and rubella vaccine PGD v04.00
- Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV13) PGD v04.00
- Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV 13) to individuals from 6 weeks of age with an underlying medical condition PGD v05.00
- Pertussis Vaccine PGD v06.00
- Pneumococcal polysaccharide vaccine (PPV23) PGD v04.00
- Rotavirus vaccine PGD v06.00
- Shingrix Vaccine PGD v02.00
- Typhoid Vi Polysaccharide Vaccine PGD v03.00
- Varicella vaccine (live) PGD v01.00
- Zostavax vaccine PGD v11.00